Vaccine- and antigen-dependent type 1 and type 2 cytokine induction after primary vaccination of infants with whole-cell or acellular pertussis vaccines

Infection and Immunity

Volumn 65, Issue 6, 1997, Pages 2168-2174

  Ausiello, Clara M ^a   Urbani, Francesca ^a   La Sala, Andrea ^a   Lande, Roberto ^a   Cassone, Antonio ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA TETANUS TOXOID; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; PERTUSSIS VACCINE;

ANTIBODY PRODUCTION; ARTICLE; BORDETELLA PERTUSSIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; HELPER CELL; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; INTERFERON PRODUCTION; PERTUSSIS; PRIORITY JOURNAL; PROTEIN INDUCTION; RANDOMIZED CONTROLLED TRIAL; VACCINATION; VACCINE PRODUCTION;

EID: 0030975947     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.65.6.2168-2174.1997     Document Type: Article

References (34)

1. Ad hoc Study Group for the Study of Pertussis Vaccines. 1988. Placebo-controlled trial of two acellular pertussis vaccines in Sweden - protective efficacy and adverse events. Lancet 31:955-960.
2. Ausiello, C. M., F. Urbani, S. Gessani, G. C. Spagnoli, M. J. Gomez, and A. Cassone. 1993. Cytokine gene expression in human peripheral blood mononuclear cells stimulated by mannoprotein constituents from Candida albicana. Infect. Immun. 61:4105-4111.
3. Ausiello, C. M., F. Urbani, A. la Sala, A. Funaro, and F. Malavasi. 1995. CD38 ligation induces discrete cytokine mRNA expression in human cultured lymphocytes. Eur. J. Immunol. 25:1477-1480.
4. Ausiello, C. M., A. la Sala, C. Ramoni, F. Urbani, A. Funaro, and F. Malavasi. 1996. Secretion of IFN-γ, IL-6, granulocyte-macrophage colony-stimulating factor and IL-10 cytokines upon CD38 ligation. Cell. Immunol. 173:192-197.
5. Bancroft, A. J., K. J. Else, and R. K. Grencis. 1994. Low-level infection with Trichuris muris significantly affects the polarization of the CD4 response. Eur. J. Immunol. 24:3113-3118.
6. Barnard, A., B. P. Mahon, J. Watkins, K. Redhead, and H. G. Mills. 1996. Th1/Th2 cell dichotomy in acquired immunity to Bordetella pertussis: variables in the in vivo priming and in vitro cytokine detection techniques affect the classification of T-cell subsets as Th1, Th2 or Th0. Immunology 87:372-380.
7. Bomford, R. 1980. The comparative selectivity of adjuvants for humoral and cell-mediated immunity. Clin. Exp. Immunol. 39:435-441.
8. Bromberg, K., G. Tannis, and P. Stainer. 1991. Detection of Bordetella pertussis associated with the alveolar macrophages of children with human immunodeficiency virus infection. Infect. Immun. 59:4715-4719.
9. Cassatella, M. A. 1995. The production of cytokines by polymorphonuclear neutrophil. Immunol. Today 16:21-26.
10. Cassone, A., C. M. Ausiello, F. Urbani, A. la Sala, R. Lande, A. Piscitelli, M. Giuliano, S. Salmaso, and Progetto Pertosse-CMI Working Group. 1997. Cell mediated and antibody responses to Bordetella pertussis antigens in children vaccinated with two acellular or one whole-cell pertussis vaccines within the Italian trial. Arch. Pediatr. Adolesc. Med. 151:283-289.
11. Chomcznski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
12. Ehlers, S., and K. A. Smith. 1991. Differentiation of T cell lymphokine gene expression: the in vitro acquisition of T cell memory. J. Exp. Med. 173:25-36.
13. Greco, D., S. Salmaso, P. Mastrantonio, M. Giuliano, A. E. Tozzi, A. Anemona, M. L. Ciofi degli Atti, A. Giammanco, P. Panei, W. C. Blackwelder, D. L. Klein, S. G. F. Wassilak and Progetto Pertosse Working Group. 1996. A controlled trial of two acellular and one whole cell vaccine against pertussis. N. Engl. J. Med. 334:341-348.
14. Greco, D., S. Salmaso, P. Mastrantonio, M. Giuliano, A. Giammanco, P. Stefanelli, A. Anemonn, A. E. Tozzi, M. L. Ciofi degli Atti, P. Panel, and S. Wassilak. A difference in the relative efficacy of two DTaP vaccines in continued blinded observation of children following a clinical trial, p. 173A. Abstracts of the Annual Meeting of the Society for Pediatric Research. Washington, D.C. May 6-10, 1996.
15. Gustafsson, L., H. O. Hallander, P. Olin, E. Reizenstein, and J. Storsaeter. 1996. A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine. N. Engl. J. Med. 334:349-335.
16. Hazenbos, W. L. W., B. M. van den Berg, J. W. van't Wout, F. R. Mool, and R. van Furth. 1994. Virulence factors determine attachment and ingestion of nonopsonized and opsonized Bordetella pertussis by human monocytes. Infect. Immun. 62:4818-4824.
17. Hostien, N. A., K. Shibuya, A. W. Heath, K. M. Murphy, and A. O'Gatta. 1995. The effects of antigen dose on CD4+ T cell phenotype development in a αβ TCR transgenic mouse model. J. Exp. Med. 182:1579-1584.
18. Kauffmann, S. H. E. 1993. Immunity to intracellular bacteria. Annu. Rev. Immunol. 11:129-163.
19. la Sala, A., F. Urbani, R. Lande, and C. M. Ausiello. 1995. A semiquantitative reverse transcriptase-polymerase chain reaction method to detect low abundance cytokine mRNA. Minerva Biotech. 7:2117-214.
20. Mahon, B. P., M. S. Ryan, F. Griffin, and K. H. G. Mills. 1996. Interleukin-12 is produced by macrophages in response to live or killed Bordetella pertussis and enhances the efficacy of an acellular pertussis vaccine by promoting induction of Th1 cells. Infect. Immun. 64:5295-5301.
21. + T-helper-cell responses in mice with low-level Candida albicans infection. Infect. Immun. 64:4907-4917.
22. Mills, K. H. G., A. Barnard, J. Watkins, and K. Redhead. 1993. Cell-mediated immunity to Bordetella pertussis: role of Th1 cells in bacterial clearance in a murine respiratory infection model. Infect. Immun. 61:399-410.
23. Mills, K. H. G. 1996. Cell mediated immunity studies from infants immunized in Sweden and pertussis vaccine efficacy studies in normal and gene knockout mice, p. 27-29. Abstracts of the National Institutes of Health Pertussis Conference, Washington, D.C., June 3-5, 1996.
24. Mosmann, T. R., and R. L. Coffman. 1989. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:145-173.
25. Munoz, J. J., H. Aral, R. K. Bergman, and P. L. Sadowski. 1981. Biological activities of crystalline pertussigen from Bordetella pertussis. Infect. Immun. 33:820-826.
26. O'Gara, A., and K. Murphy. 1994. Role of cytokines in determining T-lymphocyte function. Curr. Opin. Immunol. 6:458-465.
27. + T-cell clones against Bontetella pertussis. Infect. Immun. 59:3768-3773.
28. Petersen, J. W., P. H. Ibsen, K. Hasløv, and I. Heron. 1992. Proliferative responses and gamma interferon and tumor necrosis factor production by lymphocytes isolated from tracheobroncheal lymph nodes and spleens of mice aerosol infected with Bordetella pertussis. Infect. Immun. 60:4563-4570.
29. Rappuoli, R. 1994. Toxin inactivation and antigen stabilization: two different uses of formaldehyde. Vaccine 12:579-581.
30. Redhead, K., J. Watkins, A. Barnard, and K. H. G. Mills. 1993. Effective immunization against Bordetella pertussis respiratory infection in mice is dependent on induction of cell-mediated immunity. Infect. Immun. 61:3190-3198.
31. Sieling, P. A., X. H. Wang, M. K. Gately, J. L. Oliveros, T. McHugh, P. F. Barnes, S. F. Wolf, L. Golkar, M. Yamamura, Y. Yogi, K. Uyemura, T. H. Rea, and R. L. Modlin. 1994. IL-12 regulates T helper type 1 cytokine responses in human infectious disease. J. Immunol. 153:3639-3647.
32. Taylor, C. 1995. Cytokines as adjuvants for vaccines: antigen-specific responses differ from polyclonal responses. Infect. Immun. 63:3241-3244.
33. Weinberg, A. D., M. English, and S. L. Swain. 1990. Distinct regulation of lymphokine production is found in fresh versus in vitro primed helper T cells. J. Immunol. 144:1800-1806.
34. Zepp, F., M. Knuf, P. Habermehl, H. J. Schmitt, C. Rebsch, P. Schmidtke, R. Clements, and M. Slaoui. 1996. Pertussis-specific cell-mediated immunity in infants after vaccination with a tricomponent aeellular pertussis vaccine. Infect. Immun. 64:4078-4084.